General Inquiries
Email: [email protected]
Main: +45 31 10 91 91
CVR/VAT no. 31348854
Ordering
Email: [email protected]
Ordering: +45 29 13 42 24
Technical Support
Email: [email protected]
News
- Press Release: Patrik Dahlen is the New CEO of Immudex
- Press Release: Immudex Announces ISO 13485 Certification to Support the Manufacturing of Clinical-Grade Dextramer® [GMP] Reagents
- Press Release: Immudex and immunAware enter partnership (June 2021)
- Press Release: Immudex launches dCODE Dextramer® (RiO), a new reagent compatible with BD Rhapsody™ Single Cell Analysis system (February 2021)
- Press Release: Immudex Collaborates With BD (June 2020)
- Are You Studying SARS-CoV-2 T-Cell Responses (April 2020)
- Innovation Requires Space - New Headquarter (February 2020)
- dCODE Dextramer® Technology - Advancing Neoantigen Screening (November 2019)
- Immudex Nominated for the Gazelle Company Awards (2018)
- Immudex Partners With 10x Genomics to Enhance Applications of Its dCODE Dextramer® Technology (September 2018)
- The dCODE Dextramer® Is Launched (March 2018)
- Press Release: The Dextramer CMV Kit - IVD is Available in the USA (January 2018)
- Press Release: Helene Kähler Hjenner is the New CEO of Immudex (February 2017)
- News: Next-level Success in Managing the World's most Prevalent virus
- Press Release: JPT-Immudex Partnership Agreement (November 2013)
- Press Release: Immudex Becomes the Provider of MHC Multimer and Elispot Proficiency Panels Service (April 2013)
- News Article: DANISH, Article in Børsen: Dako-knopskud ser milliardpotentiale (November 2011)
- Press Release: ENGLISH, Ernst & Young: Immudex wins Life Sciences category Entrepreneur Of The Year 2011 (November 2011)
- News Article: DANISH, Article in Børsen: Dako-arvinger satser millioner på biotek (December 2010)
- Press Release: ENGLISH, Immudex, a New Spin-out from Dako (October 2009)